These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6307195)

  • 21. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
    Kassa J; Kuca K; Cabal J; Paar M
    J Toxicol Environ Health A; 2006 Oct; 69(20):1875-82. PubMed ID: 16952906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Kunesova G
    J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for an intramuscular depot of the cholinesterase inhibitor soman in the rat.
    Van Helden HP; Wolthuis OL
    Eur J Pharmacol; 1983 May; 89(3-4):271-4. PubMed ID: 6307710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat.
    Clement JG
    Biochem Pharmacol; 1982 Apr; 31(7):1283-7. PubMed ID: 7092921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidotal efficacy of pyridinium chloride derivatives against soman poisoning.
    Vrdoljak AL; Lovrić J; Radić B; Zlender V
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):17-21. PubMed ID: 16867165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antidotal efficacy of the bispyridinium oximes K027 and TMB-4 against tabun poisoning in mice.
    Berend S; Radić B; Kuca K; Lucić Vrdoljak A
    Chem Biol Interact; 2010 Sep; 187(1-3):291-4. PubMed ID: 20138854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning.
    Berend S; Vrdoljak AL; Radić B; Kuca K
    Chem Biol Interact; 2008 Sep; 175(1-3):413-6. PubMed ID: 18547553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The benefit of combinations of oximes for the reactivating and therapeutic efficacy of antidotal treatment of sarin poisoning in rats and mice.
    Kassa J; Karasova JZ; Sepsova V; Caisberger F
    Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):30-4. PubMed ID: 21235715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinesterase and carboxylesterase activities in soman poisoned rats treated with bispyridinium mono-oximes HI-6 and HS-6.
    Sterri SH; Lyngaas S; Fonnum F
    Biochem Pharmacol; 1983 May; 32(10):1646-9. PubMed ID: 6860351
    [No Abstract]   [Full Text] [Related]  

  • 31. The 3,3'-bis-pyridinium mono-oximes as antidotes against organophosphorous intoxication.
    Sikder AK; Pandey KS; Jaiswal DK; Dube SN; Kumar D; Husain K; Bhattacharya R; Das Gupta S
    J Pharm Pharmacol; 1992 Dec; 44(12):1038-40. PubMed ID: 1361555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HI-6 therapy of soman and tabun poisoning in primates and rodents.
    Hamilton MG; Lundy PM
    Arch Toxicol; 1989; 63(2):144-9. PubMed ID: 2730339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone- and dose schedule-dependent protection by HI-6 against soman and tabun poisoning.
    Lundy PM; Goulet JC; Hand BT
    Fundam Appl Toxicol; 1989 Apr; 12(3):595-603. PubMed ID: 2659414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of nerve agent inhibited muscle force production in human intercostal muscle strips with HI 6.
    Seeger T; Niessen KV; Langer P; Gerhardus J; Worek F; Friess H; Bumm R; Mihaljevic AL; Thiermann H
    Toxicol Lett; 2011 Sep; 206(1):72-6. PubMed ID: 21803135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicology and pharmacology of bispyridium oximes--insight into the mechanism of action vs Soman poisoning in vivo.
    Clement JG
    Fundam Appl Toxicol; 1981; 1(2):193-202. PubMed ID: 6897946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of parasympatholytics on the therapeutic effectiveness of the oxime HI-6 against organophosphorus compounds (Soman, substance VX, Fosdrin) in mice].
    Kassa J; Vachek J
    Cas Lek Cesk; 1997 Feb; 136(4):124-6. PubMed ID: 9221183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic and therapeutic efficacy of the soman-simulator, pinacolyl dimethylphosphinate.
    Van Helden HP; van der Wiel HJ; Wolthuis OL
    J Pharm Pharmacol; 1986 Jun; 38(6):439-45. PubMed ID: 2873220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HI6 as an antidote to soman poisoning in rhesus monkey respiratory muscles in-vitro.
    Smith AP; Wolthuis OL
    J Pharm Pharmacol; 1983 Mar; 35(3):157-60. PubMed ID: 6132972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New simulators in the prophylaxis against soman poisoning: structural specificity for the depot site(s).
    Van Helden HP; Benschop HP; Wolthuis OL
    J Pharm Pharmacol; 1984 May; 36(5):305-8. PubMed ID: 6145765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.